Eduovisual
Perioperative & Surgical Care
Postoperative urinary retention
— Incidence ranges 5–70% depending on surgery type; highest after anorectal, inguinal hernia, joint arthroplasty (especially hip/knee), pelvic, and spinal procedures.
— Affects roughly 1 in 6 surgical patients overall; far more common in men >60, those with BPH, and after neuraxial anesthesia.
— Patient unable to void within 6 hours of surgery completion or catheter removal.
— Suprapubic discomfort, fullness, restlessness, agitation (especially in elderly), or unexplained tachycardia/hypertension in PACU.
— Overflow incontinence — small-volume dribbling masquerading as adequate output.
— Decreased urine output flagged by nursing despite adequate fluid resuscitation.
— Detrusor underactivity from anesthetics (especially spinal/epidural), opioids, anticholinergics.
— Bladder overdistention during surgery (most preventable cause).
— Pain-induced sympathetic outflow → increased bladder neck tone.
— Pre-existing bladder outlet obstruction (BPH, urethral stricture, prior pelvic radiation).
Step 3 management: When a postoperative patient hasn't voided in 6 hours, your first move is bedside bladder scan — not reflexive catheterization. A volume >600 mL with inability to void confirms POUR and justifies in-and-out catheterization; lower volumes warrant continued observation, ambulation, and reassessment in 1–2 hours.
— Patient 4–8 hours post-op, has received IV fluids, reports lower abdominal discomfort, urgency without ability to void, or paradoxically denies symptoms entirely (especially under residual sedation or neuraxial block).
— Nursing reports "hasn't urinated since surgery" or small frequent voids of 30–50 mL (overflow).
— Suprapubic pressure, lower abdominal fullness, sensation of incomplete emptying.
— Agitation, confusion, or delirium in elderly — may be the only manifestation.
— Tachycardia, hypertension, diaphoresis from autonomic response to distention.
— Nausea, vomiting from vagally mediated reflex with severe distention.
— Patient factors: age >60, male sex, BPH, prior POUR, neurologic disease (Parkinson, MS, diabetic neuropathy, stroke, spinal cord injury), preoperative urinary symptoms (AUA score >5).
— Medications: anticholinergics, antihistamines, TCAs, opioids, alpha-agonists, benzodiazepines, beta-blockers.
— Surgical factors: anorectal, inguinal hernia, hip/knee arthroplasty, gynecologic, pelvic, spine surgery; surgery duration >2 hours; intraoperative fluids >750–1000 mL.
— Anesthetic factors: spinal/epidural (especially long-acting agents like bupivacaine), general > regional in some studies, intrathecal opioids.
— Onset usually within first 24 hours post-op or within hours of Foley removal.
— Late-onset POUR (>48 hours) — suspect infection, hematoma, constipation, new medication, or unrecognized neurologic injury.
Board pearl: A male >60 undergoing inguinal hernia repair under spinal anesthesia who received >1 L of IV fluid is the prototypical POUR vignette. Recognizing this risk constellation pre-op lets you minimize fluids, choose short-acting spinal agents, and plan early voiding trial — tested as quality improvement intervention.
Key distinction: Anuria from AKI produces no urine and an empty bladder on scan; POUR produces no voiding but a full bladder. Always scan before reflexive nephrology workup or fluid bolus.
— Palpable, dull suprapubic mass extending toward umbilicus — bladder volume >500 mL is usually palpable in non-obese patients.
— Dullness to percussion above pubic symphysis; tympany suggests bowel rather than bladder.
— Tenderness over bladder dome; rebound or guarding suggests alternative pathology (peritonitis, hematoma).
— Inspect for urethral meatus patency, blood at meatus (urethral injury), or catheter trauma.
— Digital rectal exam (DRE) in men: enlarged prostate, prostate tenderness (prostatitis), fecal impaction (a reversible POUR contributor).
— Pelvic exam in women if clinically indicated: prolapse, mass, hematoma after gynecologic surgery.
— Perineal sensation (S2–S4), anal tone, bulbocavernosus reflex, lower extremity strength and reflexes.
— Loss of perineal sensation or saddle anesthesia after spine surgery → cauda equina syndrome — surgical emergency.
— Residual motor or sensory block after neuraxial anesthesia — expected but should resolve in hours.
— Tachycardia and hypertension from sympathetic surge of distention — frequently misattributed to pain or volume status.
— Bradycardia and hypotension in severe distention via vagal reflex — uncommon but described.
— Postoperative delirium with agitation — bladder distention is on the short list of reversible triggers (alongside pain, hypoxia, hypoglycemia, infection).
— Quantifies volume; >500–600 mL with inability to void is diagnostic.
— Far superior to palpation; sensitivity of physical exam alone is poor, especially in obese or post-op tender abdomens.
CCS pearl: In a CCS case with postoperative tachycardia and agitation, order "bladder scan" before escalating to telemetry, troponin, or sedatives. Treating undiagnosed bladder distention with benzodiazepines worsens retention and delirium — a classic patient safety pitfall.
— First and most important test. Non-invasive, immediate, reproducible.
— Volume >500–600 mL with inability to void = POUR.
— Volume 300–500 mL with symptoms — observe, ambulate, reassess in 30–60 min.
— Volume <200 mL — POUR unlikely; investigate alternative (AKI, dehydration).
— Pitfalls: ascites, ovarian cysts, large fibroids, or pelvic hematoma can falsely elevate readings; morbid obesity reduces accuracy.
— After voiding attempt, scan again. PVR >200 mL is abnormal; >400 mL strongly indicates incomplete emptying and risk of recurrent retention.
— Used to guide voiding trial success vs. need for re-catheterization.
— Obtain at time of catheterization if fever, dysuria, cloudy urine, leukocytosis, or prolonged catheter dwell.
— Routine UA on every POUR episode is not indicated and increases overdiagnosis of asymptomatic bacteriuria.
— BMP to assess BUN/creatinine — rule out post-renal AKI from prolonged retention or pre-existing CKD.
— Glucose if diabetic (hyperglycemia worsens neuropathic bladder dysfunction).
— CBC if infection or hematoma suspected.
— Formal pelvic/renal ultrasound if obstruction at higher level suspected (hydronephrosis, clot retention after urologic surgery).
— CT abdomen/pelvis for suspected pelvic hematoma, abscess, or surgical complication compressing bladder/urethra.
Step 3 management: Diagnosis of POUR is clinical + bladder scan — do not order CT or formal ultrasound first. The exam pattern: "Which is the most appropriate next step?" → bedside bladder ultrasound, not Foley, not CT, not BMP. Reflexive Foley placement without scan is a low-value, CAUTI-promoting choice.
Board pearl: A PVR persistently >400 mL after two voiding trials in 24 hours is the threshold at which most institutions transition to clean intermittent catheterization (CIC) and urology consultation.
— POUR persisting >48–72 hours despite catheter management.
— Recurrent POUR after multiple failed voiding trials.
— POUR with neurologic findings (saddle anesthesia, lower extremity weakness, new bowel dysfunction).
— Hematuria, suspected urethral injury, or post-urologic/gynecologic surgery complication.
— Generally deferred until at least 6 weeks post-op to allow resolution of transient causes.
— Identify detrusor underactivity, bladder outlet obstruction, or neurogenic dysfunction.
— Indicated when retention persists and surgical or pharmacologic intervention is being considered.
— Indicated for persistent retention with hematuria, suspected stricture, clot retention, or after urethral instrumentation trauma.
— Performed by urology; not a primary Step 3 ordering decision but should be recognized as appropriate consult-driven workup.
— Emergent MRI for any postoperative retention with saddle anesthesia, bilateral leg weakness, or new bowel incontinence after spine, epidural, or pelvic surgery.
— Evaluate for epidural hematoma, abscess, or cauda equina compression — surgical emergencies with narrow time-to-decompression window (<24–48 h).
— Suspected bladder or urethral injury after pelvic trauma, hysterectomy, or difficult catheterization with blood at meatus.
— Never force a Foley if urethral injury suspected — obtain retrograde urethrogram first.
— Serial creatinine if prolonged obstruction caused post-renal AKI; expect post-obstructive diuresis after decompression — monitor electrolytes and replace volume judiciously.
CCS pearl: In a postoperative spine patient with new urinary retention plus saddle anesthesia or lower extremity weakness, the correct CCS sequence is: bladder scan → catheterize → STAT MRI lumbar spine → neurosurgery consult, not urology. Missing cauda equina is a high-stakes board trap.
Key distinction: Urodynamics is an outpatient, delayed study — never the right answer for acute POUR in the first 72 hours.
— High-risk patients: male >60, BPH/AUA score >5, prior POUR, neurologic disease, anorectal/hernia/joint/pelvic/spine surgery.
— Consider pre-op alpha-blocker (tamsulosin 0.4 mg daily x 5 days) for high-risk men undergoing elective surgery — reduces POUR incidence ~30–50%.
— Document baseline voiding pattern; treat constipation pre-op.
— Limit IV fluids to <1 L when feasible in high-risk patients.
— Prefer short-acting spinal agents (lidocaine, mepivacaine) over bupivacaine when neuraxial used.
— Place intraoperative Foley for surgeries >3 hours or with anticipated large fluid shifts; remove within 24 hours to minimize CAUTI.
— Use multimodal analgesia (acetaminophen, NSAIDs, regional blocks) to minimize opioids.
— Encourage voiding within 6 hours of surgery completion or catheter removal.
— Ambulation, privacy, warm water, running tap, sitting position for men if appropriate.
— If unable to void at 6 hours → bedside bladder scan.
— Volume <300 mL → continue observation, IV fluids if hypovolemic.
— Volume 300–500 mL with symptoms → ambulate, reassess in 30–60 min.
— Volume >500–600 mL or symptomatic distention → in-and-out catheterization (preferred over indwelling).
— Recurrent failure (2+ episodes) → indwelling Foley for 24–48 hours or transition to clean intermittent catheterization (CIC) every 4–6 hours.
— Straight (in-and-out) catheter preferred — lower CAUTI risk than indwelling Foley.
— Indwelling Foley if anticipated need >2 catheterizations or severe distention requiring slow decompression.
Step 3 management: The board-favored sequence is scan → straight cath if >500 mL → trial of void in 4–6 hours → re-scan. Avoid the trap of placing an indwelling Foley as a "just in case" measure — every catheter day adds ~5% CAUTI risk.
Board pearl: Rapid decompression of >1 L acutely was historically feared to cause hematuria/hypotension; current evidence shows complete drainage is safe — do not clamp.
— Tamsulosin 0.4 mg PO daily — uroselective alpha-1A blocker; relaxes bladder neck and prostatic smooth muscle.
— Alfuzosin 10 mg PO daily — alternative with similar efficacy.
— Indications: prophylaxis in high-risk men pre-op (start 3–5 days before surgery); treatment after first POUR episode to facilitate successful voiding trial.
— Side effects: orthostatic hypotension (especially with first dose), retrograde ejaculation, intraoperative floppy iris syndrome — disclose to ophthalmologist if cataract surgery planned.
— Continue at least 3–7 days after catheter removal; longer if BPH symptoms persist.
— Bethanechol 10–50 mg PO TID — muscarinic agonist intended to stimulate detrusor.
— Evidence is weak; not routinely recommended. Contraindicated in asthma, bradycardia, peptic ulcer, mechanical obstruction, hyperthyroidism, recent bowel anastomosis.
— May be considered for detrusor underactivity without outlet obstruction in select cases.
— Discontinue or dose-reduce opioids, anticholinergics (diphenhydramine, scopolamine, oxybutynin), TCAs, benzodiazepines.
— Switch to multimodal non-opioid analgesia: scheduled acetaminophen + NSAID + regional anesthesia.
— Treat constipation aggressively — bowel distention worsens retention; senna, polyethylene glycol, bisacodyl as needed.
— Treat UTI if symptomatic and confirmed; do not treat asymptomatic bacteriuria from catheterization.
— Optimize glycemic control in diabetics with neurogenic bladder.
— 5-alpha reductase inhibitors (finasteride, dutasteride) — too slow-acting (3–6 months) for acute POUR management; useful for chronic BPH prevention only.
— Anticholinergics for overactive bladder in the acute POUR setting — paradoxically worsen retention.
Board pearl: A high-yield Step 3 stem: man with BPH develops POUR after inguinal hernia repair → start tamsulosin, perform voiding trial in 24–48 hours. Adding finasteride is a distractor — wrong timeframe.
Step 3 management: Always reconcile the medication list when treating POUR — anticholinergic burden is a reversible contributor frequently missed on rounds.
— First-line invasive intervention for POUR with bladder volume >500–600 mL.
— 14–16 Fr Foley or straight catheter; sterile technique; complete drainage.
— Lowest CAUTI risk of catheter options.
— Repeat as needed every 4–6 hours if retention recurs.
— Use when: anticipated multiple catheterizations within 24 h, severe distention (>1 L), inability to perform CIC, hemodynamic compromise from distention.
— Duration: 24–48 hours, then voiding trial.
— Every catheter-day increases CAUTI risk ~3–7% — daily reassessment of necessity is a CMS quality metric.
— Use silver-alloy or antimicrobial catheters when prolonged dwell expected.
— Remove Foley in morning to allow daytime voiding observation.
— Patient should void within 4–6 hours; measure PVR by bladder scan.
— Success: spontaneous void >150 mL with PVR <200 mL.
— Failure: unable to void, void <150 mL, or PVR >300–400 mL → replace catheter, consider longer course or CIC.
— For patients with persistent retention requiring discharge before resolution.
— Self-catheterization every 4–6 hours; clean (not sterile) technique acceptable at home.
— Lower infection rate than indwelling Foley; preserves dignity and mobility.
— Requires patient teaching; nursing/home health support critical.
— Indicated when urethral access impossible (stricture, urethral injury, recent urethral surgery) or prolonged catheterization anticipated.
— Placed by urology; reduces urethral trauma and may have lower CAUTI risk in long-term use.
— Rare in acute POUR; reserved for persistent bladder outlet obstruction (TURP, urethrotomy for stricture) after urodynamics confirm fixed obstruction not responsive to medical therapy.
CCS pearl: On CCS, after placing a catheter for POUR, the next orders are "remove Foley in 24–48 hours" + "voiding trial" + "bladder scan post-void." Forgetting to discontinue the catheter triggers CAUTI scoring penalties.
Key distinction: Straight cath = preferred for single episodes; Foley = recurrent or severe; CIC = discharge with ongoing retention; suprapubic = urethral access blocked.
— Highest-risk demographic; age >70 doubles POUR risk independent of sex.
— Polypharmacy review: STOPP/Beers criteria flag anticholinergics, antihistamines, opioids, benzodiazepines, TCAs as POUR-promoting.
— Delirium presentation: agitation, inattention, or hypoactive delirium may be the only sign — always bladder scan in postoperative delirium workup alongside hypoxia, pain, glucose, infection.
— Lower threshold for alpha-blocker trial; start at lowest effective dose to avoid orthostasis and falls.
— Tamsulosin in elderly: monitor for orthostatic hypotension, particularly with concurrent antihypertensives or first dose at bedtime.
— Tamsulosin, alfuzosin — primarily hepatic metabolism; no dose adjustment for CKD.
— Bethanechol — caution in CKD; can precipitate bradyarrhythmias.
— Post-obstructive diuresis after relieving prolonged retention can be substantial — monitor urine output, replace with 0.45% NS at ~50–75% of hourly losses, follow electrolytes (Na, K, Mg, phosphate) every 6–12 hours.
— Acute kidney injury from retention usually resolves within 24–72 hours of decompression; persistent AKI warrants nephrology consult.
— Tamsulosin metabolized by CYP3A4 and CYP2D6; avoid in severe hepatic impairment (Child-Pugh C) or reduce dose.
— Avoid combining with strong CYP3A4 inhibitors (ketoconazole, ritonavir, clarithromycin) — increases hypotension risk.
— Pre-op cognitive screen (Mini-Cog) and frailty assessment identify patients at risk for prolonged POUR and post-op delirium.
— Plan early mobilization, avoid restraints (worsen delirium and retention), and minimize tethering devices including unnecessary Foleys.
Step 3 management: In a confused 82-year-old post-hip-arthroplasty patient, bladder scan is part of the delirium workup, before adding antipsychotics. Treating retention often resolves the delirium without pharmacologic intervention.
Board pearl: Post-obstructive diuresis >200 mL/h for >2 hours warrants active fluid replacement and electrolyte monitoring — failure to replace can produce hypovolemic shock in the elderly.
— POUR after vaginal delivery (especially operative) or cesarean affects up to 15% of patients.
— Risk factors: epidural analgesia, prolonged second stage, instrumental delivery, perineal trauma, large birthweight infant.
— Management: bladder scan, in-and-out catheterization, voiding trial within 6 hours of delivery or epidural cessation.
— Avoid bethanechol in breastfeeding; tamsulosin is not routinely used in postpartum women but considered safe if needed (limited data).
— Covert (asymptomatic) postpartum retention can cause long-term bladder dysfunction — protocols mandate post-delivery voiding documentation.
— POUR less common but occurs after hypospadias repair, inguinal hernia, circumcision, anorectal procedures.
— Bladder volume thresholds weight-based (~10 mL/kg or expected bladder capacity = [age + 2] × 30 mL).
— Prefer non-pharmacologic measures (warm bath, distraction, privacy); catheterize if symptomatic and confirmed by scan.
— Alpha-blockers used off-label; pediatric urology guidance recommended.
— Often on baseline CIC; perioperative plan should continue home CIC schedule.
— Autonomic dysreflexia in patients with SCI above T6 — bladder distention triggers severe hypertension, headache, bradycardia — immediate decompression is treatment.
— Standard Foley dwell 5–14 days depending on procedure; cystogram before removal in some cases.
— Retention after Foley removal is common; may need re-catheterization.
— Anterior colporrhaphy, sling procedures, hysterectomy carry high POUR risk (15–30%).
— Voiding trial protocols routine; discharge with CIC if needed.
CCS pearl: Postpartum patient who hasn't voided 6 hours after epidural removal — bladder scan first, then straight cath if >500 mL. Missing postpartum retention can lead to chronic detrusor injury and lifelong voiding dysfunction — a high-impact, low-cost intervention.
Key distinction: In SCI patients with bladder distention and hypertension/headache → think autonomic dysreflexia, not pheochromocytoma — decompress the bladder first.
— Prolonged overdistention (>1 L for hours) → detrusor muscle ischemia and stretch injury, predisposing to chronic atonic bladder and recurrent retention.
— Bladder rupture is rare but reported with extreme distention plus trauma.
— Each catheter-day adds 3–7% risk of bacteriuria; symptomatic CAUTI ~3–10% of patients with prolonged Foley.
— CAUTI is a CMS hospital-acquired condition (HAC) with reimbursement penalties.
— Most common organisms: E. coli, Klebsiella, Enterococcus, Pseudomonas, Candida (especially in diabetics, antibiotic-exposed).
— Do not treat asymptomatic bacteriuria in catheterized patients — exception: pregnancy, pre-urologic procedure.
— Post-renal AKI from prolonged obstruction; usually reversible with decompression.
— Post-obstructive diuresis may produce hypovolemia and electrolyte disturbances.
— Traumatic catheterization → false passage, urethral stricture, bleeding, urethrocutaneous fistula.
— Higher risk with forceful insertion in men with BPH; consider coude-tip catheter or urology assistance.
— Common after rapid decompression; usually self-limited.
— Persistent gross hematuria → cystoscopy.
— POUR adds 1–2 days to LOS and increases 30-day readmission risk; tracked as a surgical quality metric.
— Untreated retention worsens delirium; catheter tubing increases fall risk and CAUTI risk simultaneously.
— A minority develop persistent voiding dysfunction requiring long-term CIC or surgical management; urodynamic-confirmed detrusor underactivity may be permanent.
Board pearl: A patient with fever, flank pain, and indwelling Foley day 4 post-op → diagnose CAUTI/pyelonephritis; treat with ceftriaxone or piperacillin-tazobactam pending cultures, and exchange or remove the catheter.
Step 3 management: The single highest-yield action to reduce POUR-related complications is daily Foley necessity review with prompt removal — a tested CMS/Joint Commission expectation.
— Failed catheterization (urethral stricture, false passage, blood at meatus).
— Recurrent POUR after 2+ failed voiding trials.
— Gross hematuria with clot retention requiring continuous bladder irrigation.
— Suspected bladder or urethral injury.
— POUR after urologic surgery (TURP, radical prostatectomy, sling).
— Need for suprapubic catheter placement.
— Cauda equina syndrome (saddle anesthesia, bilateral lower extremity weakness, bowel dysfunction) — emergent MRI then decompression.
— Spinal epidural hematoma or abscess after neuraxial anesthesia — time-critical surgical emergency.
— Persistent neuraxial blockade > expected duration.
— Suspected intrathecal opioid-related retention requiring naloxone trial.
— Hemodynamic instability from autonomic dysreflexia or severe distention.
— Sepsis from CAUTI/pyelonephritis — IV antibiotics, ICU if shock.
— Acute kidney injury with electrolyte disturbance or oliguria post-decompression.
— Inability to manage CIC at home without resources.
— Single POUR episode, successful voiding trial, stable vitals, no infection, intact mental status, reliable patient/caregiver.
— Discharge with alpha-blocker + outpatient urology follow-up in 1–2 weeks.
— Discharge with indwelling Foley or CIC if voiding trial failed but patient otherwise stable — trial of void in clinic in 5–7 days.
— Clear discharge instructions: catheter care, signs of UTI, when to call (no urine output >4 h, fever, gross hematuria, flank pain).
— Home health referral for CIC teaching when indicated.
— Communicate with PCP about ongoing alpha-blocker and follow-up urology appointment.
CCS pearl: In CCS, a patient with POUR + saddle anesthesia post-laminectomy → immediate orders: "MRI lumbar spine STAT," "neurosurgery consult STAT," "NPO," "Foley catheter." Do not delay imaging for labs.
Step 3 management: Discharging a patient home with a Foley requires explicit return precautions and a scheduled voiding trial — undocumented = liability and readmission.
— Often the underlying chronic substrate that POUR unmasks.
— Pre-existing nocturia, weak stream, hesitancy, AUA score elevation.
— Management overlaps with POUR: alpha-blockers, catheter decompression, urology follow-up; consider TURP if recurrent.
— Suggested by difficulty passing catheter, prior catheterization history, prior STI, prior pelvic radiation, or trauma.
— Diagnosis: retrograde urethrogram, cystoscopy.
— Management: dilation, urethrotomy, or urethroplasty.
— Post-prostatectomy or post-TURP complication.
— Presents with progressive retention months to years after surgery.
— After TURP, bladder biopsy, radical prostatectomy, pelvic trauma.
— Bladder distention from blood clots obstructing the catheter.
— Treatment: large-bore (22–24 Fr) three-way Foley with continuous bladder irrigation, manual clot evacuation.
— Chronic intermittent retention; suggested by hematuria, recurrent UTI, imaging.
— Fever, pelvic pain, tender boggy prostate on DRE.
— Treat with antibiotics covering gram-negatives (ciprofloxacin, TMP-SMX); abscess requires drainage.
— Hematuria, weight loss, smoking history, age; cystoscopy diagnostic.
— Underactive detrusor from diabetic autonomic neuropathy, MS, prior stroke, spinal cord injury.
— Urodynamics confirm; long-term CIC commonly required.
— Pure detrusor failure from anesthesia, opioids, or pain — most common scenario.
Board pearl: Difficulty passing the catheter despite proper technique → urethral stricture or false passage → stop, obtain urology consult, consider flexible cystoscopy-guided placement. Do not force.
Key distinction: Clot retention is a Foley-occluded retention scenario — the catheter is in place but the bladder is full; irrigation, not removal, is the answer.
— Low urine output, empty bladder on scan, dry mucosa, tachycardia, hypotension, elevated BUN/Cr ratio >20:1, FENa <1%.
— Treatment: fluid resuscitation, not catheterization.
— From prolonged hypotension, contrast, aminoglycosides, NSAIDs.
— Muddy brown casts, FENa >2%, isosthenuric urine.
— Not a catheter problem.
— Can mimic bladder distention on exam; bladder scan distinguishes.
— Tympany on percussion vs. dullness of full bladder.
— Compresses bladder neck; contributes to and exacerbates POUR.
— DRE diagnostic; disimpaction and laxatives part of POUR management.
— After hysterectomy, C-section, colorectal surgery — ureteral ligation or bladder laceration.
— Anuria with normal bladder volume after pelvic surgery → suspect bilateral ureteral injury; CT urogram, urology emergent consult.
— ACEi/ARB + NSAID + diuretic (the "triple whammy") → AKI, low UOP, empty bladder.
— Distributive shock with prerenal AKI; fever, leukocytosis, lactic acidosis.
— Postoperative MI or heart failure → reduced renal perfusion, low UOP.
— Hypotension-driven decreased UOP; bladder empty.
Key distinction: The single most useful bedside maneuver to distinguish POUR from AKI is the bladder scan: full bladder = POUR (post-renal/functional outlet); empty bladder = pre/intrarenal cause. This is a recurring board distinguisher.
Step 3 management: When postoperative urine output drops, the algorithm is: bladder scan first → if full, catheterize; if empty, assess volume status, check creatinine, review meds, consider AKI workup. Do not give an empiric fluid bolus before scanning.
— Alpha-blocker (tamsulosin 0.4 mg daily) for men with POUR and any LUTS — continue ≥1 month, then reassess with urology.
— Hold or taper anticholinergics, sedating antihistamines, TCAs if possible.
— Optimize bowel regimen (PEG, senna) — constipation is a modifiable POUR risk factor.
— Continue non-opioid analgesia (acetaminophen, NSAIDs if appropriate) to minimize opioid burden.
— No catheter (preferred): successful voiding trial, PVR <200 mL, no symptoms.
— Indwelling Foley: failed voiding trial; schedule outpatient trial of void in 5–7 days with urology or PCP.
— CIC: failed voiding trial with preserved manual dexterity; home health teaching; trial of spontaneous voiding in 1–2 weeks.
— Document POUR episode prominently in chart and patient-held records.
— Pre-op alpha-blocker for next elective procedure if male with BPH/prior POUR.
— Communicate with anesthesia: prefer short-acting neuraxial agents or general anesthesia depending on context.
— Minimize intraoperative fluids; use multimodal analgesia.
— Pre-emptive intraoperative Foley with early removal protocol if surgery >3 hours.
— Fluid timing (limit evening fluids), caffeine and alcohol reduction.
— Pelvic floor and bladder training in patients with mixed symptoms.
— Treat OSA, optimize diabetes — both contribute to neurogenic dysfunction.
— Recurrent POUR despite medical therapy → discussion of TURP, prostatic urethral lift (UroLift), water vapor thermal therapy (Rezum), or laser enucleation with urology.
— 5-alpha reductase inhibitors (finasteride, dutasteride) for long-term prostate volume reduction (men with prostate >40 g) — adjunct, not acute therapy.
Board pearl: Tamsulosin reduces recurrent POUR by ~30–50% in men with BPH undergoing repeat surgical procedures — a tested perioperative quality intervention.
Step 3 management: Document the POUR diagnosis on the discharge summary and ensure PCP and surgeon both receive notification with explicit follow-up plan — closing the transition-of-care loop is a tested safety expectation.
— Patient discharged without catheter: PCP visit within 1–2 weeks; urology only if recurrent symptoms or BPH workup needed.
— Patient discharged with Foley: trial of void in 5–7 days with urology or trained PCP; bladder scan post-void for PVR.
— Patient on CIC: urology follow-up in 1–2 weeks; assess whether spontaneous voiding has resumed.
— Failed second voiding trial: schedule urodynamic studies in 4–6 weeks to characterize bladder dysfunction.
— Voiding diary (frequency, volume, urgency, nocturia) — useful for both diagnosis and treatment response.
— Serial PVR measurements (bladder scan) at follow-up visits.
— Urinalysis only if symptoms; avoid routine cultures of asymptomatic patients.
— Serum creatinine at 1 week post-discharge if prior AKI.
— Catheter care: secure to leg, drainage bag below bladder level, daily hygiene with soap and water, no antiseptic ointments routinely.
— Signs to seek care: no urine output >4 hours with catheter, fever >38°C, gross hematuria with clots, flank pain, severe suprapubic pain.
— Hydration goals: ~1.5–2 L/day; avoid bolus drinking; reduce caffeine and alcohol.
— Medication reconciliation: review for anticholinergic burden; provide written list of medications to avoid.
— Patient arrives with full bladder, catheter removed, attempts to void; PVR measured.
— Pass: void >150 mL with PVR <200 mL → no further intervention; reassess in 2–4 weeks.
— Fail: replace catheter; consider extended catheterization or urodynamics.
— Address embarrassment, sexual function concerns (retrograde ejaculation with tamsulosin), and impact on daily activities.
— Provide written instructions and contact information for symptom-triggered escalation.
CCS pearl: "Schedule follow-up appointment" in 1–2 weeks is a frequently tested CCS-style order for post-POUR discharge — neglecting follow-up scheduling is penalized in scoring.
Board pearl: PVR >300 mL persistently at follow-up is the threshold to refer for urodynamics and consider definitive BPH or neurogenic bladder management.
— Catheterization is invasive and carries risks (UTI, urethral injury, false passage, discomfort).
— Obtain verbal consent at minimum; document indication, risks, alternatives, and patient agreement.
— In incapacitated patients (sedation, dementia, delirium), use surrogate decision-making for non-emergent catheterization; emergent placement for severe distention falls under implied consent.
— CAUTI is a CMS hospital-acquired condition with reimbursement penalties; many hospitals track catheter-days as a public quality metric.
— Daily Foley necessity review is a Joint Commission expectation.
— Inappropriate Foley use (convenience, urine output monitoring without clinical need) is a documented safety event.
— Reflexively placing a Foley for postoperative oliguria without scanning may miss AKI, hypovolemia, or surgical bleeding.
— Conversely, attributing post-op delirium to "sundowning" without checking for retention misses a reversible cause.
— Discharging with a catheter requires explicit communication to PCP, home health, and patient; documentation of catheter type, insertion date, and planned removal date.
— Failure to schedule the voiding trial is a frequently identified readmission driver in surgical quality reviews.
— Use structured discharge tools (e.g., teach-back) to confirm patient understanding of catheter care and warning signs.
— CAUTI events typically reported to NHSN (CDC National Healthcare Safety Network).
— Document time of catheter placement, indication, and removal in EHR — required for quality reporting.
— Jehovah's Witness or other patients refusing blood products with gross hematuria/clot retention — discuss alternatives (irrigation, tranexamic acid, embolization) and respect autonomy with documented informed refusal.
— Cognitively impaired patients who self-discontinue catheters — assess capacity, address discomfort/agitation, avoid restraints; consider whether catheter is truly necessary.
Step 3 management: Every Foley order should be paired with a planned stop date or daily reassessment order — a defendable, tested safety practice. The "set it and forget it" Foley is the prototypical patient safety failure on board vignettes.
Board pearl: Documenting indication, planned duration, and daily reassessment for every catheter is the medico-legal standard and the most tested aspect of catheter stewardship.
Board pearl: The single most tested teaching point: scan the bladder before placing a Foley — applies to retention, oliguria, delirium, and post-op tachycardia of unclear cause.
Step 3 management: Recognize the high-risk perioperative cluster — older man + BPH + neuraxial anesthesia + inguinal hernia/joint replacement + high IV fluids — and intervene with pre-op tamsulosin, fluid restraint, and early voiding trial.
— 68-year-old man, 6 hours post-inguinal hernia repair under spinal anesthesia, complains of lower abdominal discomfort and inability to void. Vitals: HR 102, BP 158/92. Suprapubic dullness noted.
— Question: Most appropriate next step? → Bedside bladder ultrasound (scan).
— Distractors: place Foley immediately, give IV furosemide, CT abdomen, BMP.
— Post-op patient with no urine output for 5 hours, BUN 32, Cr 1.6 (baseline 0.9).
— Question: Best initial step? → Bladder scan to distinguish post-renal (POUR) from prerenal AKI.
— Distractors: IV fluid bolus, nephrology consult, renal ultrasound, urinalysis.
— 82-year-old, post-op day 1 from hip arthroplasty, agitated, pulling at IV lines, last voided in OR.
— Question: Next step? → Bladder scan (delirium workup includes retention).
— Distractors: haloperidol, lorazepam, restraints, head CT.
— Post-laminectomy patient with urinary retention, perineal numbness, bilateral leg weakness.
— Question: Next step? → STAT MRI lumbar spine and neurosurgery consult.
— Distractors: bladder scan only, urology consult, urinalysis.
— 70-year-old with BPH scheduled for elective inguinal hernia repair, prior POUR after cholecystectomy.
— Question: Best preventive measure? → Start tamsulosin 0.4 mg daily 3–5 days pre-op.
— Distractors: finasteride, prophylactic Foley, regional anesthesia avoidance, oxybutynin.
— Patient with indwelling Foley day 5 develops fever 38.9°C, flank pain, leukocytosis.
— Question: Diagnosis and management? → CAUTI/pyelonephritis → urine culture, empiric IV antibiotics, remove or exchange catheter.
— G1P1 8 hours after vaginal delivery with epidural, hasn't voided, suprapubic fullness.
— Question: Next step? → Bladder scan; in-and-out catheterization if >500 mL.
— Day 3 post-op Foley, urine culture grows E. coli 100,000 CFU, patient asymptomatic afebrile.
— Question: Management? → Remove unnecessary catheter; do NOT treat asymptomatic bacteriuria.
Board pearl: Pattern recognition — "bladder scan" is the single most common correct answer across POUR question stems on Step 3.
Step 3 management: When stem includes "no urine output" or "hasn't voided" — pause before ordering Foley, fluids, or labs. Scan first, then act.
Postoperative urinary retention is a common, largely preventable perioperative complication best managed by recognizing high-risk patients pre-operatively, confirming the diagnosis with bedside bladder ultrasound (volume >500–600 mL with inability to void), decompressing with the least invasive catheter option, and treating with alpha-blockers while addressing reversible contributors and minimizing CAUTI risk through prompt catheter removal.
— Scan first, cath second: Bedside bladder ultrasound is the single most important diagnostic step — distinguishes POUR (full bladder) from AKI/hypovolemia (empty bladder) and prevents unnecessary catheterization. Volume >500–600 mL with inability to void = POUR.
— Tamsulosin 0.4 mg daily is the first-line pharmacotherapy for both prevention (pre-op 3–5 days in high-risk men) and treatment of POUR; continue ≥1 month with urology follow-up. Counsel about orthostasis and floppy iris syndrome before cataract surgery.
— Catheter stewardship is patient safety: Prefer in-and-out (straight) catheterization over indwelling Foley; if Foley required, plan removal within 24–48 hours with structured voiding trial. Each catheter-day raises CAUTI risk 3–7% — CAUTI is a CMS-tracked hospital-acquired condition with reimbursement consequences.
— Red flag escalation: POUR with saddle anesthesia, bilateral leg weakness, or new bowel dysfunction = suspect cauda equina syndrome → emergent MRI lumbar spine and neurosurgery consult. POUR with fever, flank pain, leukocytosis while catheterized = CAUTI/pyelonephritis → cultures, empiric IV antibiotics, catheter exchange or removal.
Board pearl: The Step 3 algorithm for any postoperative patient with decreased urine output, suprapubic discomfort, or unexplained agitation is invariably the same — bladder scan → straight catheterize if retention → tamsulosin → plan voiding trial → daily catheter necessity review → safe transition of care with explicit follow-up.
Step 3 management: Document indication, planned removal date, and daily reassessment for every catheter; reconcile anticholinergic medications; minimize opioids; schedule PCP and urology follow-up; provide written return precautions — this discharge bundle prevents readmission and is the tested standard of care.